Royal College of Pharmacy in England
We support, promote and lead the pharmacy profession across all sectors of pharmacy in England.
The Royal College of Pharmacy is a GB-wide organisation, but there are significant differences in policy in England, Scotland and Wales. That’s why England has its own National Pharmacy Advisory Council and RCPharm England team: to ensure we understand and support all our members and the wider profession in England.
Email us at [email protected]
Contact your RCPharm Regional Ambassador.
-
Open letter to the PDA following their statement about the RPS Special Resolution Vote process
This letter was published when the organisation was the Royal Pharmaceutical Society. We are disappointed by the position taken by the Pharmacists’ Defence Association (PDA) regarding the RPS forthcoming Special Resolution Vote (SRV) of Members and Fellows of the Royal Pharmaceutical Society (voting is open between 13th-24th March 2025). These proposals are made by the RPS Assembly, our governing body, to modernise our Charter (subject to Privy Council approvals) and make us fit for our future as a professional leadership body in response to the changing pharmacy landscape. We have also applied for registration with the charity regulators to form the Royal College of Pharmacy. After an extensive period of engagement with our members and wider stakeholders about the proposed changes to our current constitution and governance, we are a matter of days away from inviting our Members and Fellows to participate in an historic vote that, if supported by two thirds of those members who vote, would see the RPS move towards becoming the Royal College of Pharmacy. This is something many have been calling for over a number of years and the time to act is now. Our proposals for change and SRV have been put forward following a democratic process during which elected members of Assembly have reviewed, amended and unanimously approved the proposals for change. In addition, colleagues then sitting on the three National Pharmacy Boards emphatically supported the proposals for change and the strengthening of their professional leadership body. RPS has been open about the progress of the Constitution and Governance review at every stage. The proposals for change and the principles behind them have been the subject of numerous member communications during 2024 and leading up to the SRV, not least during the engagement roadshows held during October and November last year. The report of which can be found here. We have been delighted with the number of RPS members who have actively engaged with us in this process, either attending meetings or webinars and those who have asked us questions in an effort to seek to better understand the proposals and the consequences of becoming a royal college. A detailed series of questions and answers can be found here and anyone with a question not already answered may send a question to us using the ‘feedback’ email and we will respond promptly and further build the FAQ. This is a significant moment in the evolution of the professional leadership body. With the support of our Members and Fellows, it will lead to a Royal College of Pharmacy that will create greater recognition for pharmacy and the scope of its impact, advance pharmacists to provide excellence in patient care, support workforce transformation and put patients at the forefront of our work. We will do this by working in collaboration to encourage, identify and showcase excellence. Member engagement, recognition and community will be at its very heart. Professional independence is a cornerstone of the current RPS and will remain a cornerstone of the future royal college. Providing a strong and respected voice championing pharmacy to government, industry and others will remain central to our work. We urge Members and Fellows to exercise their vote and support the unanimous recommendation of the RPS Assembly members, who together with our National Pharmacy Boards and alongside a wide range of pharmacy stakeholders, are endorsing the proposals for the new Charter and to become the Royal College of Pharmacy. Sincerely, Professor Claire Anderson FFRPS FRPharmS, RPS President Brendon Jiang FRPharmS, RPS Treasurer Jonathan Burton FRPharmS, Scottish Pharmacy Board Chair and RPS Assembly member Geraldine McCaffrey MRPharmS, Welsh Pharmacy Board Chair and RPS Assembly member Tase Oputu FRPharmS, English Pharmacy Board Chair and RPS Assembly member Paul Bennett FRPharmS, RPS CEO
-
Renew or join by 28 February to vote on Royal College status says RPS
RPS is urging pharmacists to renew their membership (if it is due) by 28th February 2025, or to join by that date, to be eligible to take part in the upcoming Special Resolution Vote on its proposals for change to become the Royal College of Pharmacy.
-
Reclassification will help unlock access to medicines says RPS
This news story was published when the organisation was the Royal Pharmaceutical Society. The Royal Pharmaceutical Society welcomes the news from the Department of Health and Social Care encouraging more reclassification applications to the Medicines and Healthcare Products Regulatory Agency. RPS is a member of the Conditions & Category Working Group, which has worked with the MHRA to identify medicines which could be reclassified from ‘available only on prescription’ (POM) to ‘available in pharmacy’ (P) to improve opportunities for self care and to enable timely and more convenient access to medicines. Six broad health conditions have been identified where medicines could be reclassified to treat allergies, pain, skin problems, digestive disorders, women's health and oral health, based on international practice and real-world evidence. Reclassification of medicines enables people to be treated for specific conditions whilst receiving informed guidance, advice and support from their pharmacy team. President of the RPS Professor Claire Anderson said: "We welcome the news that applications for POM to P switches are being encouraged in six therapeutic areas. Reclassification can provide people with easier access to treatments for a range of symptoms and encourages self-care. “Diagnosing and discussing health problems with patients and advising on the benefits and risks of treatment options are integral to the role of the pharmacy team. “Enabling POM to P switches has a critical role to play in managing demand in primary care. It helps minimise unnecessary GP appointments and A&E attendances for minor conditions and ensures the public get the treatment they need from community pharmacies. “As the professional leadership body for pharmacists, RPS will work closely with the MHRA and manufacturers to provide guidance ensuring what is provided to the public continues to be safe and appropriate for their condition.” Read more RCPharm news stories.
Our work in England
Our vision for England
Our vision for the role of and value of pharmacists and pharmacy teams.
Pharmacy practice
Working with NHS England and APTUK on inclusive pharmacy practice.
Future of pharmacy
The NHS in England is changing. Find out what this means for pharmacy.
How we work in England
National Pharmacy Advisory Council
Meet the elected council for England and find out how it works.
The Royal College of Pharmacy England team
Supporting members and leading pharmacy in England.
Our policy and advocacy work
Find out more about the College’s policy and advocacy work.